Purpose
|
Roflumilast is a phosphodiesterase-4 (PDE-4) inhibitor. Due to its selective inhibition of the PDE4 isoenzyme in lung cells, roflumilast is indicated for the management of chronic obstrtuctive pulmonary disease (COPD) exacerbations. Treatment with Roflumilast is associated with an increase in psychiatric adverse reactions, including suicide and suicidal attempts.
|
Characteristics
|
Source of Compound: synthetic Target: PDE inhibitor Receptor: PDE4
|
Purification
|
All the products are sent with COA, HPLC and NMR inspection report to guarantee the quality.
|
Purity
|
99?%
|
Formula
|
C17H14Cl2F2N2O3
|
Solubility
|
DMSO 81 mg/mL, Ethanol 15 mg/mL
|